Skip to main content

and
  1. Article

    Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework

    Carmine Zoccali, Francesca Mallamaci, Jean-Michel Halimi in Nature Reviews Nephrology (2024)

  2. No Access

    Article

    Chronic cardiovascular–kidney disorder: a new conceptual framework

    The current nomenclature for cardiorenal syndrome is problematic owing to its chronological approach and the systemic nature of some of the subtypes. We suggest adoption of a new concept, chronic cardiovascula...

    Carmine Zoccali, Francesca Mallamaci, Jean-Michel Halimi in Nature Reviews Nephrology (2024)

  3. No Access

    Article

    Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer

    Chronic kidney disease is prevalent, affecting more than one in ten adults. In this population, metabolic acidosis is considered a key underlying pathophysiological feature, tying together bone mineral disorde...

    Sidar Copur, Alan A. Sag, Baris Afsar in International Urology and Nephrology (2020)

  4. No Access

    Article

    Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study

    Since inflammation alters vascular permeability, including vascular permeability in the lung, we hypothesized that it can be an amplifier of lung congestion in a category of patients at high risk for pulmonary...

    Claudia Torino, Luna Gargani, Rosa Sicari, Krzysztof Letachowicz in Journal of Nephrology (2020)

  5. Article

    Author Correction: Lipid management in patients with chronic kidney disease

    In the acknowledgements section of this article as originally published, information on the authors’ roles as EURECAm members is missing. The correct acknowledgement is as follows: “This Review was planned as ...

    Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay in Nature Reviews Nephrology (2019)

  6. No Access

    Article

    Lipid management in patients with chronic kidney disease

    An increased risk of cardiovascular disease, independent of conventional risk factors, is present even at minor levels of renal impairment and is highest in patients with end-stage renal disease (ESRD) requiri...

    Charles J. Ferro, Patrick B. Mark, Mehmet Kanbay in Nature Reviews Nephrology (2018)

  7. Article

    Open Access

    Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

    Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier in BMC Nephrology (2017)

  8. Article

    Open Access

    Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study

    Low and high blood potassium levels are common and were both associated with poor outcomes in patients with chronic kidney disease (CKD). Whether such relationships may be altered in CKD patients receiving opt...

    Sandra Wagner, Marie Metzger, Martin Flamant, Pascal Houillier in BMC Nephrology (2017)

  9. Article

    The systemic nature of CKD

  10. CKD is an inherently systemic disease

  11. Energy balance, innate immunity and neuroendocrine control of organ f...

  12. Carmine Zoccali, Raymond Vanholder, Ziad A. Massy in Nature Reviews Nephrology (2017)

  13. No Access

    Article

    Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?

    After three large neutral trials in which renal artery revascularization failed to reduce cardiovascular and renal morbidity and mortality, renal artery stenting became a therapeutic taboo. However, this is pr...

    Patricia Van der Niepen, Patrick Rossignol in Current Hypertension Reports (2017)